Inventor
BROWN DUNCAN
US23 patents
⚠️ This page may combine multiple inventors who share the name “BROWN DUNCAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SIRNA THERAPEUTICS INC
14 patentsUS9879262B2Jan 30, 2018
RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)
SIRNA THERAPEUTICS INC12 citations91
US9464290B2Oct 11, 2016
RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (siNA)
SIRNA THERAPEUTICS INC11 citations91
US8835623B2Sep 16, 2014
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
SIRNA THERAPEUTICS INC15 citations91
US10793860B2Oct 6, 2020
RNA interference mediated inhibition of hepatitis B virus (HBV) gene expression using short interfering nucleic acid (SINA)
SIRNA THERAPEUTICS INC5 citations83
US10407682B2Sep 10, 2019
RNA interference mediated inhibition of hepatitis B Virus (HBV) gene expression using short interfering nucleic acid (siNA)
SIRNA THERAPEUTICS INC7 citations83
US9850491B2Dec 26, 2017
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
SIRNA THERAPEUTICS INC5 citations82
US9447420B2Sep 20, 2016
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA)
SIRNA THERAPEUTICS INC6 citations82
US11332745B2May 17, 2022
RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (SINA)
SIRNA THERAPEUTICS INC1 citations70
US10577606B2Mar 3, 2020
RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)
SIRNA THERAPEUTICS INC2 citations70
US10729787B2Aug 4, 2020
Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety
SIRNA THERAPEUTICS INC2 citations69
US10004814B2Jun 26, 2018
Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety
SIRNA THERAPEUTICS INC2 citations69
US11952573B2Apr 9, 2024
RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)
SIRNA THERAPEUTICS INC0 citations60
US11529428B2Dec 20, 2022
Systemic delivery of myostatin short interfering nucleic acids (siNA) conjugated to a lipophilic moiety
SIRNA THERAPEUTICS INC0 citations59
US10246714B2Apr 2, 2019
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
SIRNA THERAPEUTICS INC0 citations51
BROWN DUNCAN
2 patentsUS8518907B2Aug 27, 2013
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
BROWN DUNCAN16 citations89
US8412485B2Apr 2, 2013
System and method of monitoring a load condition of a vehicle
BROWN DUNCAN12 citations82